TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 77 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,311,765 | +45.0% | 73,819 | +47.4% | 0.00% | – |
| Q2 2023 | $904,964 | +123.6% | 50,081 | +55.6% | 0.00% | – |
| Q1 2023 | $404,690 | +11.1% | 32,195 | +29.5% | 0.00% | – |
| Q4 2022 | $364,404 | -12.4% | 24,857 | +2.4% | 0.00% | – |
| Q3 2022 | $416,000 | -18.8% | 24,270 | -30.9% | 0.00% | – |
| Q2 2022 | $512,000 | +172.3% | 35,119 | +213.3% | 0.00% | – |
| Q1 2022 | $188,000 | -25.7% | 11,211 | -0.2% | 0.00% | – |
| Q4 2021 | $253,000 | -58.9% | 11,238 | -60.6% | 0.00% | – |
| Q3 2021 | $615,000 | +155.2% | 28,530 | +244.5% | 0.00% | – |
| Q2 2021 | $241,000 | -8.4% | 8,282 | +30.0% | 0.00% | – |
| Q4 2020 | $263,000 | – | 6,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,779,158 | $32,149,385 | 4.73% |
| COWEN AND COMPANY, LLC | 1,999,383 | $36,128,850 | 3.00% |
| Vivo Capital, LLC | 2,262,200 | $40,877,954 | 2.82% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $32,300,613 | 1.93% |
| Cormorant Asset Management, LP | 1,421,422 | $25,685,096 | 1.44% |
| Sands Capital Ventures, LLC | 260,000 | $4,698,200 | 1.39% |
| Ghost Tree Capital, LLC | 150,000 | $2,710,500 | 0.90% |
| RTW INVESTMENTS, LP | 2,548,125 | $46,044,619 | 0.88% |
| Perceptive Advisors | 1,296,416 | $23,426,237 | 0.68% |
| TFG Asset Management GP Ltd | 165,000 | $2,981,550 | 0.40% |